| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 1 | - | 7.3 | 62.3 | - | - | - | - | 70.7 |
| - | - | - | - | 9 | 54 | - | - | - | - | 63 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 210 | 99.5% | -0.15 | 189 | 100.0% |
| Optic-unspecified(R) | 1 | 0.5% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns LA_ME_unclear | % In | CV |
|---|---|---|---|---|---|
| LA_ME_unclear (R) | 3 | ACh | 39 | 57.1% | 0.1 |
| Cm17 (R) | 2 | GABA | 5.7 | 8.3% | 0.1 |
| Cm19 (R) | 3 | GABA | 4 | 5.9% | 0.5 |
| Tm30 (R) | 1 | GABA | 2.7 | 3.9% | 0.0 |
| aMe17b (R) | 1 | GABA | 2.7 | 3.9% | 0.0 |
| Cm7 (R) | 3 | Glu | 2.7 | 3.9% | 0.6 |
| Cm15 (R) | 1 | GABA | 2.3 | 3.4% | 0.0 |
| Cm26 (R) | 1 | Glu | 2 | 2.9% | 0.0 |
| C3 (R) | 1 | GABA | 2 | 2.9% | 0.0 |
| Cm21 (R) | 1 | GABA | 1.7 | 2.4% | 0.0 |
| Mi16 (R) | 1 | GABA | 1 | 1.5% | 0.0 |
| Cm9 (R) | 1 | Glu | 0.7 | 1.0% | 0.0 |
| Tm6 (R) | 1 | ACh | 0.3 | 0.5% | 0.0 |
| DNc02 (L) | 1 | unc | 0.3 | 0.5% | 0.0 |
| Tm37 (R) | 1 | Glu | 0.3 | 0.5% | 0.0 |
| T2a (R) | 1 | ACh | 0.3 | 0.5% | 0.0 |
| HBeyelet (R) | 1 | HA | 0.3 | 0.5% | 0.0 |
| Cm29 (R) | 1 | GABA | 0.3 | 0.5% | 0.0 |
| downstream partner | # | NT | conns LA_ME_unclear | % Out | CV |
|---|---|---|---|---|---|
| LA_ME_unclear (R) | 3 | ACh | 39 | 14.6% | 0.1 |
| Tm5c (R) | 8 | Glu | 26.7 | 10.0% | 0.4 |
| TmY5a (R) | 6 | Glu | 24 | 9.0% | 0.3 |
| MeTu3c (R) | 5 | ACh | 22.3 | 8.4% | 0.9 |
| TmY10 (R) | 5 | ACh | 21.3 | 8.0% | 0.4 |
| Tm29 (R) | 6 | Glu | 19.3 | 7.3% | 0.6 |
| Tm37 (R) | 5 | Glu | 14.7 | 5.5% | 0.8 |
| Mi10 (R) | 5 | ACh | 11.3 | 4.3% | 0.6 |
| aMe5 (R) | 2 | ACh | 11 | 4.1% | 0.0 |
| Tm5a (R) | 5 | ACh | 10.3 | 3.9% | 0.7 |
| Tm31 (R) | 1 | GABA | 9.7 | 3.6% | 0.0 |
| Tm5Y (R) | 3 | ACh | 6.7 | 2.5% | 0.5 |
| Cm1 (R) | 4 | ACh | 5.7 | 2.1% | 0.6 |
| ME_unclear (R) | 1 | Glu | 5 | 1.9% | 0.0 |
| TmY13 (R) | 1 | ACh | 3.7 | 1.4% | 0.0 |
| Cm19 (R) | 2 | GABA | 3.7 | 1.4% | 0.5 |
| Cm7 (R) | 4 | Glu | 3 | 1.1% | 0.6 |
| Cm26 (R) | 1 | Glu | 2.3 | 0.9% | 0.0 |
| Dm4 (R) | 2 | Glu | 2.3 | 0.9% | 0.7 |
| Cm17 (R) | 3 | GABA | 2 | 0.8% | 0.4 |
| Pm12 (R) | 1 | GABA | 2 | 0.8% | 0.0 |
| Tm20 (R) | 2 | ACh | 1.3 | 0.5% | 0.5 |
| Tm4 (R) | 1 | ACh | 1.3 | 0.5% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 1.3 | 0.5% | 0.0 |
| MeTu3b (R) | 3 | ACh | 1.3 | 0.5% | 0.4 |
| Tm5b (R) | 3 | ACh | 1.3 | 0.5% | 0.4 |
| Tm39 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| Tm12 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| Cm29 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| Cm3 (R) | 1 | GABA | 0.7 | 0.3% | 0.0 |
| Cm15 (R) | 1 | GABA | 0.7 | 0.3% | 0.0 |
| MeVP12 (R) | 1 | ACh | 0.7 | 0.3% | 0.0 |
| C2 (R) | 1 | GABA | 0.7 | 0.3% | 0.0 |
| Cm8 (R) | 1 | GABA | 0.7 | 0.3% | 0.0 |
| Mi18 (R) | 1 | GABA | 0.7 | 0.3% | 0.0 |
| Cm31b (R) | 1 | GABA | 0.7 | 0.3% | 0.0 |
| Mi2 (R) | 1 | Glu | 0.7 | 0.3% | 0.0 |
| Dm8a (R) | 2 | Glu | 0.7 | 0.3% | 0.0 |
| T2 (R) | 2 | ACh | 0.7 | 0.3% | 0.0 |
| Tm30 (R) | 1 | GABA | 0.7 | 0.3% | 0.0 |
| T2a (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| Cm11b (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| aMe17b (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| Mi15 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| Cm4 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| Mi13 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| Dm8b (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| Dm11 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| C3 (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| Cm11c (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |